Viking Therapeutics, Inc. (VKTX)

Viking Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	33.88	26.68	55.52	36.63	26.37	29.12
Short-Term Investments	773.84	875.94	306.56	118.85	175.73	219.27
Cash & Short-Term Investments	807.72	902.61	362.08	155.49	202.1	248.39
Cash Growth	-14.28%	149.29%	132.87%	-23.07%	-18.63%	-9.89%
Prepaid Expenses	2.82	1.13	2.52	3.41	0.62	0.44
Other Current Assets	16.48	3.48	2.62	8.14	7.81	7.28
Total Current Assets	827.02	907.22	367.23	167.04	210.53	256.1
Property, Plant & Equipment	0.78	1	1.13	1.42	0.03	0.32
Long-Term Deferred Charges	0.01	0.06	0.11	0.04	0.08	0.05
Other Long-Term Assets	0.05	0.05	0.03	0.03	0.03	0.03
Total Assets	827.85	908.32	368.49	168.53	210.66	256.5
Accounts Payable	5.49	9.81	7.51	8.53	1.44	3.99
Accrued Expenses	26.02	17.11	11.3	13.11	7.31	7.81
Current Portion of Leases	0.47	0.49	0.32	0.3	0.03	0.33
Total Current Liabilities	31.98	27.41	19.14	21.95	8.78	12.13
Long-Term Leases	0.41	0.63	0.94	1.26	-	0.03
Total Liabilities	32.39	28.04	20.07	23.21	8.78	12.16
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,395	1,369	733.55	445.27	425.61	412.59
Retained Earnings	-599.1	-487.91	-377.94	-292.05	-223.18	-168.19
Treasury Stock	-	-	-6.8	-6.8	-	-
Comprehensive Income & Other	-0.17	-0.79	-0.39	-1.1	-0.55	-0.05
Shareholders' Equity	795.46	880.28	348.42	145.32	201.88	244.34
Total Liabilities & Equity	827.85	908.32	368.49	168.53	210.66	256.5
Total Debt	0.88	1.12	1.26	1.56	0.03	0.36
Net Cash (Debt)	806.85	901.49	360.82	153.92	202.07	248.03
Net Cash Growth	-14.27%	149.85%	134.42%	-23.83%	-18.53%	-9.80%
Net Cash Per Share	7.23	8.27	3.82	2.00	2.62	3.42
Filing Date Shares Outstanding	112.44	112.25	100.49	78.42	78.36	74.13
Total Common Shares Outstanding	112.33	111.57	100.11	78.26	78.25	73.22
Working Capital	795.04	879.8	348.09	145.09	201.75	243.98
Book Value Per Share	7.08	7.89	3.48	1.86	2.58	3.34
Tangible Book Value	795.46	880.28	348.42	145.32	201.88	244.34
Tangible Book Value Per Share	7.08	7.89	3.48	1.86	2.58	3.34

Updated Apr 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q